3 completed, 3 unknown, 1 active not recruiting, 1 not yet recruiting. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 3, Unknown 3, Active not recruiting 1, Not yet recruiting 1 |
Follow Non-Small-Cell Lung Cancer: new trials by email Literature Review of Non-Small-Cell Lung Cancer trials Research Report on Non-Small-Cell Lung Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC Cryoablation - Non-Small-Cell Lung Cancer | Phase 4 | Not yet recruiting | Shanghai Chest Hospital | 20 | 2024-10-01 | 2024-08-30 |
| Lorlatinib Continuation Study Lorlatinib - Non-Small-Cell Lung Cancer, NSCLC | Phase 4 | Active not recruiting | Pfizer | 76 | 2021-12-28 | 2026-09-23 |
| Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study Elemene plus first or third generation EGFR-TKIs, First or third generation EGFR-TKIs - Carcinoma, Non-Small-Cell Lung Cancer | Phase 4 | Unknown | Tian Xie | 744 | 2020-11-09 | 2023-12-27 |
| Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer Erlotinib, Gefitinib, Icotinib - Non-Small-Cell Lung Cancer | Phase 4 | Unknown | Qilu Hospital of Shandong University | 250 | 2014-01-01 | 2016-03-29 |
| Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases Icotinib plus WBRT - Non-small-cell Lung Cancer | Phase 4 | Unknown | Betta Pharmaceuticals Co., Ltd. | 80 | 2013-06-01 | 2015-07-15 |
| Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC) Concurrent chemoradiotherapy (paclitaxel plus cisplatin plus radiotherapy) - Non-small-cell Lung Cancer | Phase 4 | Completed | Taipei Veterans General Hospital, Taiwan | 6 | 2008-04-01 | 2011-09-15 |
| Pemetrexed Followed by Docetaxel or in Reverse Sequence Docetaxel and pemetrexed - Non-small-cell Lung Cancer | Phase 4 | Completed | Taipei Veterans General Hospital, Taiwan | 44 | 2008-03-01 | 2011-09-29 |
| Non-small Cell Lung Cancer Registry zoledronic acid - Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant | Phase 4 | Completed | Novartis Pharmaceuticals | 300 | 2004-11-01 | 2009-11-23 |
Carcinoma, Non-Small-Cell Lung (8) · Lung Neoplasms (3) · Adenocarcinoma (1) · Carcinoma (1) · Pleural Effusion, Malignant (1)
Bronchial Neoplasms (8) · Carcinoma, Bronchogenic (8) · Lung Diseases (8) · Neoplasms (8) · Neoplasms by Site (8) · Respiratory Tract Diseases (8) · Respiratory Tract Neoplasms (8) · Thoracic Neoplasms (8) · Lung Neoplasms (5) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Pleural Diseases (1) · Pleural Effusion (1) · Pleural Neoplasms (1)
Cisplatin (2) · Docetaxel (2) · Pemetrexed (2) · icotinib (2) · Carboplatin (1) · Chemoradiotherapy (1) · Cryosurgery (1) · Erlotinib Hydrochloride (1) · Gefitinib (1) · Paclitaxel (1) · Platinum (1) · Radiotherapy (1) · Zoledronic Acid (1) · aflutinib (1) · aumolertinib (1)
Taipei Veterans General Hospital, Taiwan (2) · Betta Pharmaceuticals Co., Ltd. (1) · Novartis Pharmaceuticals (1) · Pfizer (1) · Qilu Hospital of Shandong University (1) · Shanghai Chest Hospital (1) · Tian Xie (1)
China (4) · Taiwan (3) · United States (2) · France (1) · India (1) · Japan (1) · Singapore (1) · Spain (1)
Yuh-Min Chen, MD, PhD. (2) · L. Lacerna, MD (1) · Wei Zhu, MD (1) · Yu Li, Professor (1) · Ziping Wang, PhD (1)
2023 (1)